Triptolide, a novel diterpenoid triepoxide fromTripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts
Abstract:Objective
Various extracts of the Chinese herbal remedy Tripterygium wilfordii Hook. f. (TWHF) have been reported to be therapeutically efficacious in rheumatoid arthritis (RA) in China, but their mechanism of action remains unclear. We investigated the effect of triptolide, a diterpenoid triepoxide from TWHF, on the production of pro–matrix metalloproteinase 1 (proMMP‐1; or procollagenase 1 or pro–interstitial collagenase 1), proMMP‐3 (or prostromelysin 1), tissue inhibitors of metalloproteinases (TIMPs), and… Show more
“…Previous studies showed that triptolide inhibited transcriptional activation through NFkB [28] and suppressed TNFa production by LPS-stimulated macrophages [23] and IL-2 production by PHA-activated T cells. [28] Our results extend these observations by showing inhibition of multiple inflammatory mediators in staphylococcal exotoxin-activated PBMC at both transcriptional and protein level.…”
Section: Discussionmentioning
confidence: 93%
“…[22] In human synovial fibroblasts, triptolide suppresses the production and expression of prometalloproteinases 1 and 3 and inhibits the expression of COX-2 and IL-1-induced PGE 2 production. [23] Triptolide also inhibits vascular endothelial cell growth factor expression in phorbol 12-myristate 13-acetate (PMA)-activated endothelial cells [24] and attenuates the expression of IL-6, IL-8, and cell adhesion molecule ICAM-1 by PMA-stimulated human bronchial epithelial cells. [25] The effects of triptolide on other cell types include the inhibition of the expression of C3, CD40, and B7H in TNFa-activated human proximal tubular epithelial cells [26] and suppression of LPS-induced TNFa, IL1b, and nitric oxide production by microglial cells.…”
Proinflammatory cytokines mediate the toxic effects of superantigenic staphylococcal exotoxins (SE) and bacterial lipopolysaccharide (LPS). Triptolide, an oxygenated diterpene derived from a traditional Chinese medicinal herb, Tripterygium wilfordii, inhibited SE-stimulated T-cell proliferation (by 98%) and expression of interleukin 1b, interleukin 6, tumor necrosis factor, gamma interferon, monocyte chemotactic protein 1, macrophage inflammatory protein (MIP)-1a, and MIP-1b by human peripheral blood mononuclear cells (PBMC). It also blocked the production of these cytokines and chemokines by LPS-stimulated PBMC in a dose-dependent manner. These results suggest that triptolide has potent immunosuppressive effects even counteracting the effects of superantigens and LPS. It also may be therapeutically useful for mitigating the pathogenic effects of these microbial products by downregulating the signaling pathways activated by both bacterial exotoxins and endotoxins.
“…Previous studies showed that triptolide inhibited transcriptional activation through NFkB [28] and suppressed TNFa production by LPS-stimulated macrophages [23] and IL-2 production by PHA-activated T cells. [28] Our results extend these observations by showing inhibition of multiple inflammatory mediators in staphylococcal exotoxin-activated PBMC at both transcriptional and protein level.…”
Section: Discussionmentioning
confidence: 93%
“…[22] In human synovial fibroblasts, triptolide suppresses the production and expression of prometalloproteinases 1 and 3 and inhibits the expression of COX-2 and IL-1-induced PGE 2 production. [23] Triptolide also inhibits vascular endothelial cell growth factor expression in phorbol 12-myristate 13-acetate (PMA)-activated endothelial cells [24] and attenuates the expression of IL-6, IL-8, and cell adhesion molecule ICAM-1 by PMA-stimulated human bronchial epithelial cells. [25] The effects of triptolide on other cell types include the inhibition of the expression of C3, CD40, and B7H in TNFa-activated human proximal tubular epithelial cells [26] and suppression of LPS-induced TNFa, IL1b, and nitric oxide production by microglial cells.…”
Proinflammatory cytokines mediate the toxic effects of superantigenic staphylococcal exotoxins (SE) and bacterial lipopolysaccharide (LPS). Triptolide, an oxygenated diterpene derived from a traditional Chinese medicinal herb, Tripterygium wilfordii, inhibited SE-stimulated T-cell proliferation (by 98%) and expression of interleukin 1b, interleukin 6, tumor necrosis factor, gamma interferon, monocyte chemotactic protein 1, macrophage inflammatory protein (MIP)-1a, and MIP-1b by human peripheral blood mononuclear cells (PBMC). It also blocked the production of these cytokines and chemokines by LPS-stimulated PBMC in a dose-dependent manner. These results suggest that triptolide has potent immunosuppressive effects even counteracting the effects of superantigens and LPS. It also may be therapeutically useful for mitigating the pathogenic effects of these microbial products by downregulating the signaling pathways activated by both bacterial exotoxins and endotoxins.
“…The inhibition of PGE 2 production was due to suppression of COX-2 . COX-1 expression was not affected (Lin et al, 2001a). As with the extracts, the inhibitory effects of 1 on PGE 2 production varied depending on the cell line studied .…”
“…Similarly, triptolide (1) suppressed expression of COX-2 and the precursor forms of MMP-1 and -3, and inhibited production of PGE 2 and NO and activity of lipoxygenase Lin et al, 2001a;Zhou et al, 2003). The inhibition of PGE 2 production was due to suppression of COX-2 .…”
“…Consistent with the effect on the proinflammatory signals, extracts strongly inhibited proliferation of T and B cells (Tao et al, 1991(Tao et al, , 1995. Pure triptolide (1) also inhibited T cell proliferation and production of TNF-α, IL-1, IL-2, IL-6, and IL-8 (Tao et al, 1995;Chan et al, 1999;Qiu et al, 1999;Lin et al, 2001a;Zhou et al, 2003). The suppression of metabolic activity in T cells was not due solely to reduction in cell viability (Chan et al, 1999).…”
Section: Antiinflammatory and Autoimmune Conditionsmentioning
Plants in the genus Tripterygium, such as Tripterygium wilfordii Hook. f., have a long history of use in traditional Chinese medicine. In recent years there has been considerable interest in the use of Tripterygium extracts and of the main bioactive constituent, the diterpene triepoxide triptolide (1), to treat a variety of autoimmune and inflammation-related conditions. The main mode of action of the Tripterygium extracts and triptolide (1) is the inhibition of expression of proinflammatory genes such as those for interleukin-2 (IL-2), inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNF-α), cyclooxygenase-2 (COX-2) and interferon-gamma (IFN-γ). The efficacy and safety of certain types of Tripterygium extracts were confirmed in human clinical trials in the US and abroad. Over 300 compounds have been identified in the genus Tripterygium, and many of these have been evaluated for biological activity. The overall activity of the extract is based on the interaction between its components. Therefore, the safety and efficacy of the extract cannot be fully mimicked by any individual constituent. This review discusses the biochemical composition and biological and pharmacological activities of Tripterygium extracts, and their main bioactive components.
To investigate the efficacy and mechanisms of matrine, a component derived from Sophora flavescens in treatment of rheumatoid arthritis (RA), a rat model of RA was established. Compared to control rats, matrine significantly mitigated inflammation and severity of RA (paw volume and articular index (AI) score). Using either mice splenic T cells stimulated with PMA/ionomycin or rat splenic T cells, the levels of Th1 and Th2 responses were determined by flow cytometry, quantitative RT-PCR, and ELISA. Furthermore, the levels of NF-κBp65 (RelA), IκBα, and phosphor-IκBα in T cells were determined by Western blot. Our study found that matrine modulated the imbalance of Th1 and Th2 cytokine responses in rats with RA by reducing the levels of Th1 cytokines (IFN-γ, TNF-α, IL-1β), but increasing Th2 cytokine (IL-4 and IL-10) through attenuating the NF-κB signaling in T cells, suggesting matrine as a promising drug for intervention of RA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.